Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NeoPharm: A Pipeline with Multiple Catalysts
One Med Place
Saturday, October 3, 2009 - 10:45am
tags:
NeoPharm
Abbott Keeps Dealing With Solvay Purchase
Yahoo/Investor's Business Daily
Saturday, October 3, 2009 - 10:08am
tags:
Abbott Laboratories, Solvay
Warning: Potential Blockbuster Ahead
Motley Fool
Saturday, October 3, 2009 - 9:40am
tags:
Bristol-Myers Squibb, AstraZeneca, Dapagliflozin, type 2 diabetes
AstraZeneca: Nektar Deal to Add Value
Yahoo/Zacks
Saturday, October 3, 2009 - 9:37am
tags:
AstraZeneca, Nektar
Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease
Yahoo/PR NewsWire
Saturday, October 3, 2009 - 9:35am
tags:
Pilcera, Gaucher disease, Amicus Therapeutics
BioCryst Clarifies Government Declaration Regarding Peramivir
Yahoo/PR NewsWire
Saturday, October 3, 2009 - 9:34am
tags:
peramivir, Biocryst
Drug stocks trade little changed; QLT rallies on sale
MarketWatch
Saturday, October 3, 2009 - 9:33am
tags:
QLT
NASDAQ warns Targeted Genetics, extension given
bizjournals.com
Saturday, October 3, 2009 - 9:30am
tags:
Targeted Genetics
Discovery Labs: Pump Up the Volume
The Street
Saturday, October 3, 2009 - 9:27am
tags:
Discovery Labs
GlaxoSmithKline: A Fountain of Youth Stock
Seeking Alpha
Friday, October 2, 2009 - 10:41am
tags:
GSK
Strange Bedfellows: Rival Medical Firms Launch Joint Stent Study
WSJ Online
Friday, October 2, 2009 - 10:39am
tags:
stents, JNJ, Boston Scientific, Medtronic, Abbott Laboratories, Bristol-Myers Squibb, Sanofi, Eli Lilly, Daiichi Sankyo
Bristol-Myers, AstraZeneca say their diabetes drug dapagliflozin succeeded in late-stage study
Yahoo/AP
Friday, October 2, 2009 - 10:38am
tags:
Bristol-Myers Squibb, AstraZeneca, diabetes, Dapagliflozin
Pfizer Email on "Negligible Evidence" for Neurontin as a Bipolar Drug Is Focus of Lawyers' Tug-of-War
BNET Pharma
Friday, October 2, 2009 - 10:36am
tags:
Pfizer, lawsuits, Neurontin, off-label
QLT sells U.S. unit for $230M
Fierce Pharma
Friday, October 2, 2009 - 10:35am
tags:
QLT, M&A, Eligard, Tolmar Holdings
Swine Flu Stocks: Where Are They Now
Seeking Alpha
Friday, October 2, 2009 - 10:31am
tags:
swine flu, H1N1, Novavax, Biocryst, AVI BioPharma, Dynavax, Vical, Sinovac
Caraco Pharmaceutical Laboratories, Forest Laboratories close Lexapro settlement deal
Yahoo/AP
Friday, October 2, 2009 - 10:30am
tags:
Forest Labs, Caraco, settlements, Lexapro
Why Orexigen's Empatic News Is Good
Seeking Alpha
Friday, October 2, 2009 - 10:29am
tags:
Orexigen, obesity, Empatic, Arena Pharmaceuticals, Vivus
Allergan Suing U.S. to Void Rules, Market Off-Label Botox Uses
Bloomberg
Friday, October 2, 2009 - 10:26am
tags:
Allergan, Botox, off-label
Eli Lilly to Double China Workforce
Seeking Alpha
Friday, October 2, 2009 - 10:24am
tags:
Eli Lilly, China
Teva rivals advance on oral MS drug: Merck KGaA and Novartis have completed Phase III trials of their drugs, and are filing for approval
Trading Markets
Thursday, October 1, 2009 - 6:27pm
tags:
Teva Pharmaceuticals, Novartis, multiple sclerosis, Merck KGaA

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.